Sea cucumber peptide formula food for special medical purposes and preparation method thereof

Abstract

The invention discloses a sea cucumber peptide formula food with a special medical purpose, and particularly relates to a food composition with a function of controlling blood sugar of type II diabetes. The formula food for special medical use comprises the following components: a) mitochondrial nutrients; b) sea cucumber peptide; c) medicinal and edible nutritional components; d) a natural sweetener. The mitochondrial nutrient is a nutrient capable of protecting complete mitochondrial structure functions or promoting mitochondrial function exertion, and at least comprises a combination of coenzyme Q10 and lipoic acid. All the components cooperate with one another, mitochondrial regeneration is promoted, islet cell repair is promoted, and the immune function and the cell metabolism function are recovered. In addition, the formula food has a fat burning effect, can eliminate toxins wrapped by fat and can remove free radicals in cells. The formula food also has the effects of recoveringblood glucose control and balancing and stabilizing blood glucose, eliminates the side effects of hypoglycemic drugs and avoids the occurrence of diabetic complications.

Description

technical field [0001] The invention relates to a sea cucumber peptide formula food for special medical use and a preparation method thereof, in particular to a formula food composition for special medical use with the function of controlling blood sugar in type II diabetes and a preparation method thereof. Background technique [0002] The number of people with diabetes continues to grow globally. According to statistics, the incidence rate accounted for less than 1% of the population in the 1980s, 4% in the 1990s, 7% in the 2000s, and 11% in the 2010s. In 2017, there were about 425 million people suffering from the disease worldwide, and it is expected to reach 629 million by 2045. my country is the country with the largest number of diabetics in the world. From the perspective of incidence, the incidence rate was 0.67% in the 1980s and 11.6% in 2013. In terms of the number of people with diabetes, it was 114 million in 2017 and is expected to reach about 150 million by 2...

AI Technical Summary

Problems solved by technology

The problem usually faced in the course of treatment is the first-line drugs, such as metformin. After about a year of use, the body gradually shows drug resistance, and blood sugar control is not up to standard (with glycosylated hemoglobin as the index, it cannot be controlled below 6.5%) ), use second-line drugs, and so on, generally 3-5 years will not be able to control blood sugar with 1-4 line oral hypoglycemic drugs, only insulin injections

But it has the following problems: 1. Every time you eat starch staple food or snacks, you must take starch blockers; 2. It does not help the recovery of pancreatic β-cells and insulin secretion; 3. Postprandial blood sugar levels, It is only one of the indicators of diabetes and can only be used as a control indicator, not an indicator of diabetes recovery

The main reason may be that the activity of sea cucumber peptides is relatively low; the protection of gastric juice to peptides is not well protected; the regulation of human metabolism is not coordinated; the activity of mitochondria and nutrient supply are not improved; "

Images